Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. (AXDX) Friday announced the pricing of its offering of $15 million of shares and in lieu of common stock to certain investors, pre-funded warrants to purchase shares.
/PRNewswire/ -- The "Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...
TUCSON, Ariz., Jan. 16, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced the launch of a proposed underwritten public offering of 4,500,000 units, each consisting of one share of...
/PRNewswire/ -- The "Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...
/PRNewswire/ -- The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...